e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Patient and partner empowerment programme for idiopathic pulmonary fibrosis
Mirjam J.G. van Manen, Adriaan van 't Spijker, Nelleke C. Tak, Carla T. Baars, Sandra M. Jongenotter, Liesbeth R. van Roon, Jitske Kraan, Henk C. Hoogsteden, Marlies S. Wijsenbeek
Source:
Eur Respir J , 49 (4) 1601596; DOI: 10.1183/13993003.01596-2016
Journal Issue:
April
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mirjam J.G. van Manen, Adriaan van 't Spijker, Nelleke C. Tak, Carla T. Baars, Sandra M. Jongenotter, Liesbeth R. van Roon, Jitske Kraan, Henk C. Hoogsteden, Marlies S. Wijsenbeek. Patient and partner empowerment programme for idiopathic pulmonary fibrosis. Eur Respir J , 49 (4) 1601596; DOI: 10.1183/13993003.01596-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Perceptions, experiences and information needs of patients with idiopathic pulmonary fibrosis (IPF): A qualitative study
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Development of a national patient charter for idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF clinical
Year: 2016
An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 4 (1) 00093-2017; 10.1183/23120541.00093-2017
Year: 2018
Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
Source: Eur Respir Rev 2012; 21: 161-167
Year: 2012
Patient journey to diagnosis of idiopathic pulmonary fibrosis (IPF) in the US
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models
Source: Eur Respir Rev 2014; 23:231-238
Year: 2014
A supportive care decision aid tool for idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
The lived experience of idiopatic pulmonary fibrosis: A qualitative study
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016
Discrepancy between patient expectations and experiences with anti-fibrotic drugs in idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Patients’ expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis.
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Patient motivation during pulmonary rehabilitation
Source: International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity
Year: 2019
Integrating early palliative care for patients with idiopathic pulmonary fibrosis and their caregivers
Source: Virtual Congress 2020 – Fear and anxiety, psychological wellbeing and prevention of psychological distress in chronic lung diseases
Year: 2020
European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity
Source: Eur Respir J 2016; 48: 282-283
Year: 2016
European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity
Source: Eur Respir J 2016; 48: 283-284
Year: 2016
Idiopathic pulmonary fibrosis (IPF): the patient journey
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
Do physicians in primary health care recognize pulmonary fibrosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept